Comparison of pharmacokinetics of glucosamine and synovial fluid levels following administration of glucosamine sulphate or glucosamine hydrochloride.
about
Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis?Crystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic propertiesThe human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination.The effects of glucosamine sulfate on intervertebral disc annulus fibrosus cells in vitro.The preventive effects of two nutraceuticals on experimentally induced acute synovitisGlucosamine supplementation demonstrates a negative effect on intervertebral disc matrix in an animal model of disc degenerationGlucosamine and chondroitin use in canines for osteoarthritis: A reviewGlucosamine therapy for knee osteoarthritis: pharmacokinetic considerations.Experimental pharmacology of glucosamine sulfate.Effects of oral glucosamine hydrochloride administration on plasma free amino acid concentrations in dogs.The Fate of Oral Glucosamine Traced by (13)C Labeling in the Dog.Metabolomic analyses of blood plasma after oral administration of D-glucosamine hydrochloride to dogs.Glucosamine and chondroitin for the treatment of osteoarthritis.Precolumn derivatization LC-MS/MS method for the determination and pharmacokinetic study of glucosamine in human plasma and urine.Anti-arthritic effect of GN1, a novel synthetic analog of glucosamine, in the collagen-induced arthritis model in rats.
P2860
Q21195259-60CC8762-8995-4570-93FC-A619157E344AQ24630640-F1624F9F-95F7-443A-9A40-D6FE7C13338EQ33679221-EAEE4DB7-AC72-4905-9F49-0B7E88D63FFCQ33774354-28AB394D-5585-4268-8C97-0F8F6FCC70F5Q33834116-A391626F-FB01-4440-B393-CAD75F37F955Q36901726-96BD8EC0-CB23-4FDC-ABE1-914F7A99E820Q37708334-3C496A81-38EE-482C-AEE0-33C9C5E0EA13Q37960179-F2B1B991-89EC-4EFB-93D4-491C50762835Q38684643-CCCE8276-DB54-4FC6-9549-E7E560681ECBQ41946210-F9020E9B-02CC-48B1-ABAA-D1DA2667924FQ41966032-394D17C1-AD0D-48B0-B169-EF14B78DCD1CQ42326567-8F7A982F-9301-449A-85CA-F6998B361611Q42330053-56FBA291-497C-495B-8908-C9BA68A4F989Q49742445-16255DA7-002F-4622-B900-0A217E35A554Q51421445-B3CE8B24-B17D-4408-9092-75E7D2173CF9
P2860
Comparison of pharmacokinetics of glucosamine and synovial fluid levels following administration of glucosamine sulphate or glucosamine hydrochloride.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Comparison of pharmacokinetics ...... or glucosamine hydrochloride.
@ast
Comparison of pharmacokinetics ...... or glucosamine hydrochloride.
@en
Comparison of pharmacokinetics ...... or glucosamine hydrochloride.
@nl
type
label
Comparison of pharmacokinetics ...... or glucosamine hydrochloride.
@ast
Comparison of pharmacokinetics ...... or glucosamine hydrochloride.
@en
Comparison of pharmacokinetics ...... or glucosamine hydrochloride.
@nl
prefLabel
Comparison of pharmacokinetics ...... or glucosamine hydrochloride.
@ast
Comparison of pharmacokinetics ...... or glucosamine hydrochloride.
@en
Comparison of pharmacokinetics ...... or glucosamine hydrochloride.
@nl
P2093
P1476
Comparison of pharmacokinetics ...... or glucosamine hydrochloride.
@en
P2093
G Beauchamp
M Meulyzer
T Vinardell
P304
P356
10.1016/J.JOCA.2008.01.006
P577
2008-03-04T00:00:00Z